Greatbatch Inc (GB)
19.75USD
9 Feb 2010
$0.13 (+0.66%)
$19.75
--
$19.84
$19.52
59,318
178,335
$23.49
$17.27
GB
About
Overall
| Beta: | 0.56 |
| Market Cap (Mil.): | $458.01 |
| Shares Outstanding (Mil.): | 23.19 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| GB | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 834.74 | 6.39 | 3.76 |
| EPS (TTM): | -94.28 | -- | -- |
| ROI: | 0.14 | 1.18 | 2.30 |
| ROE: | 0.29 | 1.76 | 2.82 |
Greatbatch sets 2008 sales view above expectations
Nov 28 (Reuters) - Greatbatch Inc on Wednesday gave preliminary revenue outlook for 2008 that topped analysts' expectations. The maker of components used in medical devices said it expects 2008 sales of $500 million to $550 million, while analysts expect sales of $387.9 million, according to Reuters Estimates.
MERGERS/DEALS (UPDATE 3)
** Software maker Intuit Inc said it agreed to buy Homestead Technologies Inc, which helps small business build Web sites and run stores over the Internet, for about $170 million. [nWEN2703]
Greatbatch to buy Swiss firm Precimed for $125 mln
NEW YORK, Nov 26 (Reuters) - Greatbatch Inc , a U.S. maker of components used in medical devices, said on Monday it will buy Switzerland's Precimed SA for about $125 million to gain entry into the orthopedic market.
UPDATE 3-Deals of the day -- mergers and acquisitions
(Adds Bradley Pharmaceuticals Inc, E-Z-EM Inc and others)
Greatbatch to buy medical device maker for $55 mln
Oct 30 (Reuters) - Greatbatch Inc said it agreed to buy Blaine, Minnesota-based Quan Emerteq LLC for about $55 million in cash to expand its vascular presence into the peripheral, coronary and neurovascular markets.
UPDATE 1-Greatbatch cuts 2007 profit, sales outlook
Sept 25 (Reuters) - Greatbatch Inc cut its 2007 earnings and sales outlook, mainly due to lower demand forecast from customers for the rest of the year.
Greatbatch cuts 2007 profit, sales outlook
Sept 25 (Reuters) - Greatbatch Inc cut its 2007 earnings and sales outlook, primarily due to lower demand forecast for the rest of the year.
UPDATE 1-TABLE-Greatbatch posts Q2 loss, ups '07 sales view
GREATBATCH INC. (in $) Latest Yr-ago qtr EPS (diluted) -0.15 0.21 EPS, adj (dil) 0.57 0.30 Net (million) -3.4 4.8 Sales (million) 78.5 70.6 Reuters Estimates: EPS $0.38, revenue $76.6 million
TABLE-Greatbatch posts Q2 loss
GREATBATCH INC. (in $) Latest Yr-ago qtr EPS as reported (diluted) -0.15 0.21 EPS, adj (dil) 0.57 0.30 Net (million) -3.4 4.8 Sales (million) 78.5 70.6 Reuters Estimates: EPS $0.38, revenue $76.6 million
Competitors
| Price | Change | |
|---|---|---|
| Boston Scientific Corporation (BSX.N) | $8.23 | +0.08 |
| Johnson & Johnson (JNJ.N) | $62.76 | +0.39 |
| Medtronic, Inc. (MDT.N) | $42.36 | +0.57 |
| Smith & Nephew plc (SN.L) | £637.50 | +2.00 |
| Sorin SpA (SORN.MI) | €1.23 | +0.03 |
| St. Jude Medical, Inc. (STJ.N) | $37.70 | +0.30 |
| Stryker Corporation (SYK.N) | $51.91 | +0.48 |
| Zimmer Holdings, Inc. (ZMH.N) | $56.08 | +0.66 |
| Morgan Crucible Company plc (MGCR.L) | £165.30 | +1.10 |
| Morgan Crucible Company plc (BA05_p.L) | £0.00 | 0.00 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
